Todd C. Davis - 27 Jan 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Director
Signature
/s/ Todd Davis
Issuer symbol
BDSI
Transactions as of
27 Jan 2022
Transactions value $
$313,882
Form type
4
Filing time
01 Feb 2022, 15:06:02
Previous filing
23 Dec 2021
Next filing
22 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +7.68K +3.14% $0.00 252K 27 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Stock Options (right to buy) Award $314K +85.8K $3.66 85.8K 27 Jan 2022 Common Stock 85.8K $3.66 Direct F2, F3
transaction BDSI Restricted Stock Units Award $0 +15.4K $0.00 15.4K 27 Jan 2022 Common Stock 15.4K $0.00 Direct F1
transaction BDSI Restricted Stock Units Options Exercise $0 -7.68K -50% $0.00 7.69K 27 Jan 2022 Common Stock 7.68K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan ("the Plan"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
F2 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
F3 The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.